Drawing for CELL PHARM

USPTO serial 78178467

CELL PHARM

Reviewed by CopyMark Law Group

Reg. 2881354Status 710
Filing date
Status date
Registration date
Sep 7, 2004
Examiner
OSBORNE, STANLEY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with CELL PHARM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Susan Upton Douglass

SUSAN UPTON DOUGLASS FROSS ZELNICK LEHRMAN & ZISSU, PC866 UNITED NATIONS PLZNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for the treatment of cancer and endocrinological diseases; analgesics, antiemetics, growth factors; anti-cancer diagnostic preparations for clinical or medical laboratory use and transdermal patches for the delivery of anti-cancer, immunotherapeutic, endocrinological and palliative care drugs; veterinary preparations for companion animals, for the treatment of cancer and endocrinological diseases; sanitary preparations, namely, medicinal oils for external useSECTION 8 - CANCELLED—
042medical research; technical and scientific consultation in the fields of pharmacology, medicine, medical regulatory affairs and industrial research services; computer hardware and software design for others; computer hardware and software development; legal servicesSECTION 8 - CANCELLED—
044medical services; veterinary servicesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 8, 2011C8..CANCELLED SEC. 8 (6-YR)—
Sep 7, 2004R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 15, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 26, 2004NPUBNOTICE OF PUBLICATION—
Mar 31, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 2, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 2, 20031.BDSec. 1(B) CLAIM DELETED—
Sep 2, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2003MAILPAPER RECEIVED—
Apr 9, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 4, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2003DOCKASSIGNED TO EXAMINER—
Mar 23, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance